|
Veru Inc
VERU's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Veru Inc 's sales fell
in I. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1142
Major Pharmaceutical Preparations industry recorded
growth of revenues by 12 %
Veru Inc net loss increased from $-8 millions, to $-9 millions in I. Quarter 2024,
• More on VERU's Growth
|
|
Veru Inc realized a net loss in trailing twelve months.
Veru Inc realized cash reduction of $ -0.1 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 5.14.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.
• More on VERU's Valuation
|
|
|
|
|
Veru Inc realized net loss in trailing twelve months.
Veru Inc realized cash outflow of $ -0.1per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 5.14.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.
Veru Inc Price to Book Ratio is at 2.84 lower than Industry Avg. of 91.98. and higher than S&P 500 Avg. of 0.01
• More on VERU's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com